Days after Russian COVID-19 vaccine trial approval, data breach forces Dr Reddy's plants shut
In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India.
Data breach prompts Dr Reddy's to shut key plants
Pharma major Dr. Reddy's Laboratories shut down its production facilities following a data ...
Serum Institute seeks alterations in clinical norms for Covid vaccine
Pune based Serum Institute of India (SII) that is conducting Phase 3 trial of the Oxford Covid-19 vaccine has approached India’s drug regulator seeking approval for changes to its protocol to broaden the horizon of the trials.
Cadila, one of India's two Covid vaccine makers, is going in for a huge capacity boost
While Cadila’s plasmid DNA candidate doesn’t use an infectious agent like others, and instead introduces the DNA sequence encoding the antigen, the other tests being done are for traditional delivery methods. Serum Institute is conducting tests for the candidate developed by Oxford University. Dr Reddy’s plans to distribute the Russian vaccine.
India declines proposal to test Sputnik-V Covid vaccine in large study
India's move comes as a setback for Russia's plan to roll-out the vaccine even before full trials show how well it works, while pushing back its efforts to win approval for the vaccine in the country that leads the world on average number of new infections.
Dr Reddy's partners with Department of Biotechnology for Sputnik V vaccine clinical trials in India
Chairman of Dr Reddys Laboratories, Satish Reddy said, "We are pleased with the collaboration with BIRAC as an advisory partner for clinical trials of the Sputnik V vaccine in India. We look forward to working with them to accelerate our efforts in bringing the vaccine to India."
Biological E gets nod for human trials of Covid-19 vaccine
India’s drug regulator has allowed Hyderabad-based Biological E to start phase-1 and 2 human trials in India for a vaccine against Covid-19.
World Bank says India can use funds for vaccine plans
The World Bank’s $1-billion support package to help India fight the novel coronavirus can be used for the country’s Covid-19 vaccine programme, an official of the global financial institution said.
GSK, Sanofi to make 200 mn doses available for COVID-19 vaccine alliance
COVAX aims to deliver 2 billion vaccine doses around the world by the end of 2021, and more than 180 nations have joined the plan. The United States and UK are leading a rush to strike deals with drugmakers to reserve supplies of experimental coronavirus vaccines.
Bharat Bio seeks nod for phase-3 trials of indigenous Covid vaccine Covaxin
The company has already approached the states for initiating phase III trials this month. As reported by ET earlier, the company has written to various states including Delhi, Uttar Pradesh, Bihar, Maharashtra, Punjab and Assam, seeking their permission and facilitation to initiate the trial.
UK study tests if BCG tuberculosis vaccine protects against coronavirus
Bacillus Calmette-Guerin (BCG) vaccine, used to protect against tuberculosis, induces a broad innate immune-system response and has been shown to protect against infection or severe illness with other respiratory pathogens.
Drug regulator asks Serum Institute to submit more information on Oxford Covid-19 vaccine
The Pune-based company is conducting phase-3 trials of the Oxford Covid-19 vaccine in India as part of international trials.
How Russia shortened the Covid vaccine race in rush to declare victory
The vaccine will be ready for wide distribution late this year or early next, officials say. That's roughly the same schedule as shots from rivals in the U.S., U.K. and China. Initial results from final-stage studies won’t be ready until November, with full data expected next year.